Projekt

International, multicenter, open-label, phase II study to investigate the efficacy and safety of multiple doses of IMAB362 in patients with advanced adenocarcinoma of the stomach or the lower esophagus

Abgeschlossen · 2011 bis 2012

Köberle Dieter, Inauen Roman, Jörger Markus